Page 1604 - Small Animal Internal Medicine, 6th Edition

1576 Index

Thyroid neoplasia, canine, 800–804 Toxoplasmosis (Continued) Transtracheal technique, for tracheal Tumor lysis syndrome, 1276, 1286, 1286f
cervical ultrasonography of, 801–802 lung involvement, 343 wash, 300–301, 301f–302f Tumor-associated erythrocytosis, 1368
chemotherapy for, 803 myocarditis caused by, 154 Transudate pleural fluid, 361–363, 361t Tunica albuginea, 994f
VetBooks.ir diagnosis of, 802 Trachea Transudative pericardial effusion, 177 computed tomography of, 250f
Transudates, pathogenesis of, 519–521,
treatment of, 1126
clinical features of, 800–802, 800f
Turbinates, nasal
520f–521f
zoonotic aspects of, 1524b
radiographic imaging of, 247–248
etiology of, 800
external beam radiation for, 803
oral antithyroid drugs for, 803–804 bronchoscopy of, 314t Trauma Turbinectomy
diaphragmatic hernia caused by,
description of, 255
cervical, 287
prognosis for, 804 collapse of 362–363 rhinotomy with, 244
radioactive iodine for, 803 airway obstruction caused by, head, 1075–1076 T wave
signs associated with, 801f–802f, 801b 380–381 laryngeal paralysis caused by, 277 abnormalities of, 48b
surgery for, 803 in cats, 334 myocarditis caused by, 155 description of, 26t, 47
treatment of, 802–804, 802f clinical features of, 334 peripheral vestibular disease caused Two-dimensional echocardiography,
Thyroid scintigraphy, 794 description of, 287 by, 1114 20–22
Thyroidectomy, 796t, 798, 798b diagnosis of, 334–336, 335f, 338 spinal cord. see Spinal cord, trauma to long-axis views, 21f, 23f
Thyroid-stimulating hormone etiology of, 333–334 uterine, 976 in parasternal position, 20f–23f
baseline serum concentration of, physical examination of, 334 Traumatic neuropathies, 1157, 1158t, 1159f short-axis views, 20f, 22f
777–778, 778f prognosis of, 337 Traumatic pneumothorax, 376 speckle tracking, 32
description of, 767 treatment of, 336–337 Tremorgenic mycotoxins, 1099b views on, 20–22
Greyhound levels of, 1363 cough associated with, 282 Tremors, 1183 Tylan. see Tylosin
recombinant human, 778–779 disorders of, 283b, 321–339 Triaditis, 573 Tylosin, 443, 515t–517t, 1437t–1438t
serum concentration of, 777–778, canine infectious tracheobronchitis. Triamcinolone, 1222t Tympanic bullae, 247, 249f
778f, 783 see Canine infectious Triatoma infestans, 1526 Type I hypersensitivity, 1211, 1212t
stimulation tests, 778–779 tracheobronchitis Tribrissen. see Type II hypersensitivity, 1211–1212,
Thyrotoxic cardiomyopathy, 790 examination of, 276 Trimethoprim-sulfadiazine 1212t
Thyrotoxicosis, 784–785 hypoplastic, 288f Trichomoniasis, 490–491, 490f Type II intervertebral disk disease, 1148
Thyrotropin, 776b radiographic diagnosis of, 288 Trichuris vulpis, 485, 1536 Type III hypersensitivity, 1212, 1212t
Thyrotropin-releasing hormone stenting of, tracheobronchomalacia, Tricuspid dysplasia Type IV hypersensitivity, 1212, 1212t
description of, 767 336–337 description of, 112 Tyrosine kinase inhibitors, 1333
stimulation tests, 778–779 Tracheal lumen, 288, 288f dog breeds affected by, 102t Tyrosine kinase receptors, 1273
Thyroxine Tracheal tubes, 384–385 echocardiographic findings, 112–113, U
description of, 774–775 Tracheal wash 113f
free, 776–778, 776b, 778f, 787f, 792f, canine chronic bronchitis evaluations radiographic findings, 103t Ulcer(s)
793 of, 326 Tricuspid insufficiency murmur, 11 corneal, 258
serum, 776b, 782, 787f, 791–793, 791t, complications of, 298–300, 299t Tricuspid regurgitation, 168 gastric, 426f
792f endotracheal technique for, 300–303 Trifexis. see Milbemycin Ulcerative colitis
Ticarcillin-clavulanate, 1437t–1438t feline bronchitis evaluations, 330–331 Trigeminal nerve, 1055, 1056t, granulomatous, 495
Tick paralysis, 1167t, 1169 heartworm disease evaluations, 206 1057–1059, 1059f histiocytic, 495
Timolol, 94t indications for, 298–300, 299t paralysis of, 1161–1162, 1162f Ulnar nerve, 1158t
Tissue factor, 221, 1387 interpretation of results, 303–305, 304f Triglycerides, 908 Ultra-low-fat diets, 435
Tissue plasminogen activator, 222, 1388 specimen handling, 303, 303f Triiodothyronine Ultrasonography
Tissue procoagulants, 1401 techniques for, 300–303 description of, 774–775 abdominal
To-and-fro murmurs, 11 transtracheal technique for, 300–301, free, 775f cancer staging using, 1288–1289
Tocodynamometry, 962, 963f–964f, 301f–302f Greyhound levels of, 1363 hyperadrenocorticism evaluations,
969–974 Tracheobronchitis, canine infectious serum, 776b 862–864, 862b, 863f–865f
Tocolytic agents, 962, 971f–972f client communication challenges supplementation of, 793f acute kidney injury, 690f
Tom, clinical conditions of, 990–1006 associated with, 321 Trilostane, 749, 871–872, 872f, 896t–897t of alimentary tract, 415
balanoposthitis in, 992–993, 993f clinical features of, 322 Trimethoprim-sulfadiazine, 386t–388t, extrahepatic bile duct obstruction,
cryptorchidism in, 990–991, 991f cough suppressants for, 323, 323t 444t, 515t–517t, 1126, 1185t–1186t, 574f
paraphimosis in, 993–996, 994f diagnosis of, 322–323 1437t–1438t of hepatobiliary system, 549–553, 549f,
persistent penile frenulum in, 992, etiology of, 321–322, 322b Tritrichomonas foetus, 399, 413 550t–551t, 551f–552f
992f prevention of, 323–324 Trochlear nerve, 1056t hypothyroidism in dogs, 774, 774f
phimosis in, 993–996 prognosis for, 323 Troponins incidental adrenal masses on, 892
priapism in, 993–996, 994f–996f treatment of, 323, 323t cardiac, 13 of larynx and pharynx, 273
scrotal dermatitis in, 992, 992f uncomplicated, 323 Greyhound levels of, 1363–1364 lower respiratory tract disorders, 295,
testicular neoplasia in, 996–997, Tracheobronchomalacia, 381 I, 1363 296f
996f–997f clinical features of, 334 Trypanosoma cruzi, 153–154, 1430, lymphadenopathy, 1415
testicular torsion in, 991, 991f diagnosis of, 334–336, 335f 1525–1526 neuromuscular system, 1064
urethral prolapse in, 992 etiology of, 333–334 Trypanosomiasis ovarian remnant syndrome findings,
Tongue margin, 448t prevalence of, 334 American, 1525–1526 983, 983f
Tongue tip necrosis, 697–698 prognosis of, 337 in dogs, 153–154 ovulation in bitch detected using, 943,
Tonsil, 448t stanozolol for, 336 Trypomastigotes, 1526 943f–944f
Tooth root abscess tracheal stenting for, 336–337 Trypsin, 620 pleural effusion evaluations, 360,
carnassial, 245–246 treatment of, 336–337 Trypsin activation peptide, 620 366
radiographic signs of, 249b Traditional stethoscope, 7, 7f Trypsin-like immunoreactivity (TLI), postpartum endometritis, 977f
Torbugesic. see Butorphanol Tramadol, 629t–630t, 974, 1196, 1197t, 400f, 413, 538–539, 625–626, 639b pregnancy diagnosis using, 950,
Torbutrol. see Butorphanol 1209t–1210t, 1268t, 1327b Trypsinogen, 621 950f
Torsades de pointes, 41 Transcervical insemination, 947–948, Tube feedings priapism findings, 995f
Torsemide, 66–67 948f enterostomy, 437 renal, 671
Total dietary fiber, in veterinary Transendoscopic ultrasonography, 636 gastrostomy, 436 septic prostatitis findings, 1003
therapeutic diets, 904t–906t Transesophageal echocardiography, jejunostomy, 437 of small intestine, 420–422, 421f
Total parenteral nutrition, for acute 32–33, 33f nasoesophageal, 435, 437 splenic mass, 1415f
pancreatitis, 632 Transfusion therapy, 1355–1358, 1357t orogastric, 435 splenic torsion findings, 1416f
Toxemia, 967 complications of, 1358 pharyngostomy, 436 splenomegaly, 1415
Toxic hepatopathy, 580–582, 580b Transfusion-associated lung injury Tubular function, renal, 662–664, 663t of stomach, 420–422
Toxocara canis, 344, 1532–1536, (TRALI), 1358 fractional clearance of electrolytes, 664 urinary incontinence, 731f, 736f
1533t–1535t Transient heart sounds, 7–9 gradual water deprivation, 664 Umbilical hernias, 1020
Toxocara cati, 1533t–1535t other, 9 osmolality, urine, 662–663 Unasyn. see Ampicillin-sulbactam
Toxoplasma gondii, 298, 304f, 965–966, Transient hypoparathyroidism, 764 urine specific gravity, 662–663 Uncinaria stenocephala, 1533t–1535t,
1126, 1177, 1429, 1440t, 1445, 1521, Transitional cell carcinoma of bladder, water deprivation test, 663 1536
1522f, 1533t–1535t, 1537f, 1538 736 Tumor(s) Unfractionated heparin, 228
Toxoplasmosis, 965–966, 1118t metastasis of, 1290t adrenal. see Adrenal tumors Upper airway obstruction syndrome,
canine, 1525 Transitional epithelial cells, 666–667, cardiac. see Cardiac tumors 279, 280f
central nervous system, 1126 667f mast cell. see Mast cell tumors Upper motor neuron
differential diagnosis of, 329t Transsphenoidal hypophysectomy, 753 nasal. see Nasal tumors paresis, 1146f
feline, 1521–1525 Transtracheal catheters, 383t, 384 perianal gland, 506 signs, 1039f–1040f, 1040